During the past decade, Rehabilitation R&D Service, Baltimore, MD conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rehabilitation R&D Service, Baltimore, MD" are "Anxiety" (1 trials), "Atherosclerosis" (1 trials), "Clostridium" (1 trials), "Comprehensive Care" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "Rehabilitation R&D Service, Baltimore, MD" in a lesser frequency.

Most popular intervention types in "Rehabilitation R&D Service, Baltimore, MD" are "Drug" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chlorthalidone" (1 trials), "Evidence-Based Quality Improvement" (1 trials), "Fidaxomicin" (1 trials), "Hydrochlorothiazide (HCTZ)" (1 trials) and "Metformin XR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rehabilitation R&D Service, Baltimore, MD" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Rehabilitation R&D Service, Baltimore, MD". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rehabilitation R&D Service, Baltimore, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rehabilitation R&D Service, Baltimore, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".